VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 51 filers reported holding VERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,381,880 | -33.6% | 758,355 | -22.2% | 3.50% | -26.6% |
| Q2 2023 | $15,642,641 | +101.9% | 975,227 | -2.7% | 4.76% | +120.3% |
| Q1 2023 | $7,747,447 | +42.7% | 1,002,257 | +256.3% | 2.16% | +28.9% |
| Q4 2022 | $5,428,260 | -9.4% | 281,257 | 0.0% | 1.68% | -12.7% |
| Q3 2022 | $5,994,000 | -97.9% | 281,257 | +7253.1% | 1.92% | -34.4% |
| Q2 2022 | $281,057,000 | +2320.2% | 3,825 | -98.0% | 2.93% | +12.0% |
| Q1 2022 | $11,613,000 | +263.1% | 190,749 | +58.3% | 2.62% | +267.8% |
| Q4 2021 | $3,198,000 | – | 120,535 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,960,231 | $40,289,000 | 12.90% |
| Kynam Capital Management, LP | 1,522,712 | $20,724,000 | 5.29% |
| Sofinnova Investments, Inc. | 3,181,442 | $43,299,000 | 3.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,825 | $281,057,000 | 2.93% |
| Octagon Capital Advisors LP | 575,000 | $7,826,000 | 2.09% |
| Vivo Capital, LLC | 666,666 | $9,073,000 | 0.91% |
| RA Capital Management | 1,578,820 | $21,488,000 | 0.57% |
| Alphabet Inc. | 301,580 | $4,105,000 | 0.22% |
| CARNEGIE MELLON UNIVERSITY | 16,060 | $219,000 | 0.11% |
| Polar Asset Management Partners Inc. | 294,300 | $4,005,000 | 0.05% |